Regenerative Medical Technology (RMTG) Total Current Liabilities (2017 - 2026)

Regenerative Medical Technology has reported Total Current Liabilities for 10 years, with the latest figure at $42.6 million in Q2 2026.

• On a quarterly basis, Total Current Liabilities rose 39.52% year-over-year to $42.6 million in Q2 2026; TTM through Jun 2026 was $42.6 million, a 39.52% increase from a year earlier, with the FY2025 full-year figure at $38.1 million, up 31.63% from the prior year.
• Total Current Liabilities was $42.6 million for Q2 2026 at Regenerative Medical Technology, up from $38.2 million in the prior quarter.
• The five-year high for Total Current Liabilities was $42.6 million in Q2 2026, with the low at $4.8 million in Q1 2022.
• Average Total Current Liabilities over 5 years is $22.5 million, with a median of $24.4 million recorded in 2023.
• The largest YoY upside for Total Current Liabilities was 363.0% in 2022 against a maximum downside of 41.26% in 2022.
• Over 5 years, Total Current Liabilities stood at $12.0 million in 2022, then jumped by 85.42% to $22.2 million in 2023, then jumped by 30.19% to $29.0 million in 2024, then jumped by 31.63% to $38.1 million in 2025, then gained by 11.76% to $42.6 million in 2026.
• The last three Total Current Liabilities figures came in at $42.6 million (Q2 2026), $38.2 million (Q1 2026), and $38.1 million (Q4 2025), per Business Quant data.